Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis.

被引：0
|
作者：
Ferro, ML [1 ]
Karim, MY [1 ]
Abbs, IC [1 ]
D'Cruz, DP [1 ]
Khamashta, MA [1 ]
Hughes, GRV [1 ]
机构：
[1] St Thomas Hosp, London, England
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1520
引用
收藏
页码：S588 / S588
页数：1
相关论文
共 50 条
  • [1] MYCOPHENOLATE MOFETIL: A POTENTIAL TREATMENT FOR REDUCING PROTEINURIA ASSOCIATED WITH MEMBRANOUS LUPUS NEPHRITIS
    Ferro, M. L.
    Karim, M. Y.
    Abbs, I. C.
    D'Cruz, D. P.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2003, 42 : 79 - 79
  • [2] Mycophenolate mofetil as the primary treatment of membranous lupus nephritis.
    Kasitanon, N
    Petri, M
    Haas, M
    Magder, L
    Fine, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S192 - S193
  • [3] Prospective study of mycophenolate mofetil in lupus membranous nephritis.
    Borba, EF
    Guedes, LKN
    Figueiredo, CP
    Christmann, RB
    Gonçalves, CR
    Bonfá, E
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S448 - S448
  • [4] The effective use of Mycophenolate mofetil in the treatment of lupus nephritis.
    Kingdon, EJ
    Psimenou, E
    Sweny, P
    Burns, A
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2563 - 2563
  • [5] Mycophenolate mofetil as treatment for the nephrotic syndrome caused by lupus nephritis.
    Duncan, N
    Cairns, T
    Griffith, M
    McLean, A
    Palmer, A
    Taube, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 379A - 379A
  • [6] Successful use of mycophenolate mofetil for lupus nephritis.
    Stephany, BR
    Holzman, LB
    McCune, WJ
    Somers, EC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 670A - 670A
  • [7] Interest of mycophenolate mofetil in children with membranous lupus nephritis
    Gargah, Tahar
    Goucha-Louzir, Rim
    Lakhoua, Mohamed Rachid
    NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (07): : 564 - 568
  • [8] Prospective study of remission induction by mycophenolate mofetil in lupus nephritis.
    Gordon, C
    Cross, J
    Adu, D
    Jayne, D
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S280 - S280
  • [9] Hydroxychloroquine is an independent predictor of complete renal remission to initial mycophenolate mofetil therapy in membranous lupus nephritis.
    Kasitanon, N
    Fine, D
    Haas, M
    Magder, L
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S192 - S192
  • [10] Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy
    Karim, MY
    Pisoni, CN
    Ferro, L
    Tungekar, MF
    Abbs, IC
    D'Cruz, DP
    Khamashta, MA
    Hughes, GRV
    RHEUMATOLOGY, 2005, 44 (10) : 1317 - 1321
12345